The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Open accessAbstract
In computing the probability that a woman is a BRCA1 or BRCA2 carrier for genetic counselling purposes, it is important to allow for the fact that other breast cancer susceptibility genes may exist. We used data from both a population based series of breast cancer cases and high risk families in the UK, with information on BRCA1 and BRCA2 mutation status, to investigate the genetic models that can best explain familial breast cancer outside BRCA1 and BRCA2 families. We also evaluated the evidence for risk modifiers in BRCA1 and BRCA2 carriers. We estimated the simultaneous effects of BRCA1, BRCA2, a third hypothetical gene ‘BRCA3’, and a polygenic effect using segregation analysis. The hypergeometric polygenic model was used to approximate polygenic inheritance and the effect of risk modifiers. BRCA1 and BRCA2 could not explain all the observed familial clustering. The best fitting model for the residual familial breast cancer was the polygenic, although a model with a single recessive allele produced a similar fit. There was also significant evidence for a modifying effect of other genes on the risks of breast cancer in BRCA1 and BRCA2 mutation carriers. Under this model, the frequency of BRCA1 was estimated to be 0.051% (95% CI: 0.021–0.125%) and of BRCA2 0.068% (95% CI: 0.033–0.141%). The breast cancer risk by age 70 years, based on the average incidence over all modifiers was estimated to be 35.3% for BRCA1 and 50.3% for BRCA2. The corresponding ovarian cancer risks were 25.9% for BRCA1 and 9.1% for BRCA2. The findings suggest that several common, low penetrance genes with multiplicative effects on risk may account for the residual non-BRCA1/2 familial aggregation of breast cancer. The modifying effect may explain the previously reported differences between population based estimates for BRCA1/2 penetrance and estimates based on high-risk families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Self-citationThe Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Self-citationEaston, D. F., Bishop, D. T., Ford, D., & Crockford, G. P. (1993) · Europe PMC (PubMed Central) · Cited by 1,243
Self-citationIncidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia
Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 939
Genetic analysis of breast cancer in the cancer and steroid hormone study.
Claus, E. B., RISCH, N. J., & Thompson, W. D. (1991) · PubMed · Cited by 911
Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Self-citationLocalization of the gene for Cowden disease to chromosome 10q22–23
Nelen, M. R., Padberg, G. W., Peeters, E. A. J., Lin, A. Y., Helm, B. V. D., Frants, R. R., Goulon, V., Goldstein, A. M., Reen, M. M. M. V., Eastern, D. F., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-114 · Cited by 668
Self-citationFamily history and the risk of breast cancer: A systematic review and meta-analysis
Pharoah, P. D. P., Day, N. E., Duffy, S., Easton, D. F., & Ponder, B. A. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<800::aid-ijc18>3.0.co;2-b · Cited by 651
Self-citationPrograms for pedigree analysis: Mendel, Fisher, and dGene
Lange, K., Weeks, D., Boehnke, M., MacCluer, J. W., & MacCluer, J. W. (1988) · Genetic Epidemiology · doi:10.1002/gepi.1370050611 · Cited by 616
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Unusual case of Smith‐Lemli‐Opitz syndrome “type II”
Seller, M. J., Russell, J., & Tint, G. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560305 · Cited by 585
Ford, D., Easton, D. F., & Peto, J. (1995) · Europe PMC (PubMed Central) · Cited by 528
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citationMathematical and Statistical Methods for Genetic Analysis
Lange, K. (2002) · Statistics for Biology and Health · doi:10.1007/978-0-387-21750-5 · Cited by 458
Whittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
How many more breast cancer predisposition genes are there?
Easton, D. F. (1999) · Breast Cancer Research · doi:10.1186/bcr6 · Cited by 315
Self-citationCancer risks in A-T heterozygotes
Easton, D. F. (1994) · International Journal of Radiation Biology · doi:10.1080/09553002.1994.11772027 · Cited by 289
Self-citationAntoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Ponder, B. A. J., & Easton, D. (2001) · Genetic Epidemiology · doi:10.1002/gepi.1014 · Cited by 289
Self-citationRe: Henderson,B.E. and Feigelson,H.S. (2000) Hormonal carcinogenesis. Carcinogenesis, 21, 427-433
Chobanyan, N. S. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.529 · Cited by 287
An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., Karp, D. D., Robert, N. J., & Risch, N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290801 · Cited by 287
Hopper, J. L., Southey, M. C., Dite, G. S., Jolley, D. J., Giles, G. G., McCredie, M. R. E., Easton, D. F., & Venter, D. J. (1999) · PubMed · Cited by 260
Self-citationModification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302366 · Cited by 252
Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries
Olsen, J. H., Hahnemann, J. M., Borresen-Dale, A.-L., Brondum-Nielsen, K., Hammarstrom, L., Kleinerman, R., Kaariainen, H., Lonnqvist, T., Sankila, R., Seersholm, N., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.121 · Cited by 237
Risk models for familial ovarian and breast cancer
Antoniou, A. C., Gayther, S. A., Stratton, J. F., Ponder, B. A. J., & Easton, D. F. (2000) · Genetic Epidemiology · Cited by 192
Self-citationMathematical and Statistical Methods for Genetic Analysis
Lange, K. L. (1997) · Statistics in the health sciences · doi:10.1007/978-1-4757-2739-5 · Cited by 148
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
Dunning, A. M., Healey, C. S., Pharoah, P., Foster, N., Lipscombe, J., Redman, K., Easton, D., Day, N. E., & Ponder, B. A. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.340 · Cited by 113
Self-citationCui, J. S., Antoniou, A. C., Dite, G. S., Southey, M. C., Venter, D. J., Easton, D. F., Giles, G. G., McCredie, M. R. E., & Hopper, J. L. (2001) · The American Journal of Human Genetics · doi:10.1086/318187 · Cited by 110
Self-citationInherited genetic predisposition in breast cancer: A population-based perspective
Rebbeck, T. R. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11+<2493::aid-cncr6>3.0.co;2-z · Cited by 73
An Association Between the Risk of Cancer and Mutations in the HRAS1 Minisatellite Locus
Krontiris, T. G., Devlin, B., & Karp, D. D. (1994) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199409000-00031 · Cited by 63
An Approximate Model of Polygenic Inheritance
Lange, K. L. (1997) · Genetics · doi:10.1093/genetics/147.3.1423 · Cited by 58
Cited by
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
Polygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Self-citationRisch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Self-citationGenetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Hung, R. J., Hall, J., Brennan, P., & Boffetta, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi318 · Cited by 525
Metadata
- Authors
- Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F.
- Venue
- British Journal of Cancer
- Published
- 2002-01
- Volume
- 86
- Issue
- 1
- Pages
- 76-83
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2117298495
- Cited by
- 495
- References
- 36
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.